주식회사 에이바이오머티리얼즈
YoutubeYoutube
InstagramInstagram - @celexo.official
YoutubeYoutube
InstagramInstagram - @celexo.official
Company

Thesis Report

<
1
2
>

Research

  • Joint Research
    • Cosmetic material derived from ginseng green tea exosomes (Company A)
    • Joint development of biomaterials such as iris (Company S)
    • Cosmetic biomaterials developed using Chinese medicinal herbs (Company C)
    • Research and development of cosmetic materials (Company ST)
    • Development of transdermal delivery materials (Company N)
    • Cosmetic material derived from licorice exosomes (Company L)
    • Cosmetic material incorporated with soluble elastin stabilization technology (Company D)
    • Cosmetic material derived from lactic acid bacteria exosomes (Company TH)
    • Cosmetic material developed with stabilized ceramide complex (Company C)
    • New stabilized cosmetic material (Company C)
  • In-house Technology Research
    • Research on plant exosome materials and research for development thereof
    • Plant Molecular Farming (Retinol, CBD)
    • Plant Cleanical Farming
    • Phytobiome material research
    • PhytoRNA material research
    • Research for the development of human adipose stem cell-derived exosomes
    • Research on next-generation facial plastic filler materials
    • Research on reprogrammed stem cell therapeutics
  • Government-supported Projects
    • Development of biomaterials using natural plant exosomes and stabilization technology (June 2021 to June 2022, MSS)
    • Development of histamine inhibition and immune system promotion materials containing natural vesicles (May to Dec. 2022, MSS)
    • Research for the commercialization of natural nanocarriers for the development of next-generation functional biomaterials (July 2022 to June 2024, MSS)
    • Development of Skin Product Development Guide by Country 2023 (March to Nov. 2023, Korea Cosmetics Industry Institute, Ministry of Health and Welfare)